Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Escalate
Severe alkalemia with arrhythmia, seizure, delirium, tetany, myocardial ischaemia, ventilatory failure or marked potassium depletion requires monitored acute and critical-care assessment. Stop exogenous alkali and active gastric or renal losses, obtain ECG, ionised calcium, magnesium and potassium, and correct volume and chloride only after defining heart, renal and respiratory constraints.
Synopsis
Identify chloride-responsive and chloride-resistant metabolic alkalosis, correct its maintenance factors and detect mixed ventilatory or electrolyte danger.
Metabolic alkalosis is a primary bicarbonate increase; respiratory compensation raises carbon dioxide, but a value outside the expected range reveals an additional respiratory disorder.
Generation and maintenance are separate: vomiting may initiate acid and chloride loss, while low effective volume, chloride depletion, hypokalaemia and reduced GFR prevent renal bicarbonate excretion.
A spot urine chloride obtained before treatment helps divide chloride-responsive disease from continuing diuretic or mineralocorticoid-driven chloride-resistant disease, but timing matters.
Key red flags
Neuromuscular alkalemia
Perioral tingling, carpopedal spasm, cramps, hyperreflexia, confusion or seizure can result from reduced ionised calcium and altered neuronal excitability.
Investigation priorities
01
Venous or arterial blood gasFirst step
Confirm alkalemia, primary bicarbonate elevation and the adequacy of respiratory compensation.
Management branches
ConfirmDefine primary and mixed alkalosis
Bicarbonate or base excess is high, pH is alkalemic or symptoms suggest altered ionised calcium.
Check pH, bicarbonate and carbon dioxide together, compare with expected compensation and identify an additional respiratory acidosis or alkalosis rather than assuming a single process.
Measure chloride, potassium, magnesium, ionised calcium and renal function, review blood pressure, volume state, ventilation and all gastrointestinal and medicine losses.
Key medicines
Intravenous 0.9% sodium chloridePrescribe through the NICE five-R fluid framework in staged volumes with reassessment, using the patient’s deficit, pressure, urine output, heart failure and renal function rather than a fixed metabolic-alkalosis total.
Potassium chloride replacementChoose oral or approved ready-diluted intravenous potassium chloride from the current measured deficit, symptoms, renal function and local chart, with repeat potassium before further dosing and monitored infusion for high-risk treatment.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.